Gene Munster: Tesla Will Fall Short of Model 3 Production Goals
*By Michael Teich*
An analyst at investment firm Loup Ventures spent three days camping out at Tesla's Fremont factory and keeping tabs on what he saw.
And what he surmised was that the electric automaker would likely produce between 4,300 and 4,900 Model 3 vehicles in the last week of June.
If you're keeping track ー that’s below the 5,000 a week target set by CEO Elon Musk in January, marking the third time the company has fallen short of expectations for the mass-market car.
But Loup managing partner Gene Munster isn't too worried.
“It would be a miss for the quarter, but still a positive for the Tesla story,” he told Cheddar in an interview Wednesday.
Wall Street's Tesla bears have raised flags about the company's rapid cash burn rate and have warned it will have to raise more money to fund Model 3 production, but if Tesla reaches 6,000 per week by the end of September, those betting against the company's stock could be in trouble.
“If they scale Model 3, that should lead to being cash-flow positive in the December quarter, which is obviously the substance of the short story on Tesla,” said Munster.
For the full segment, [click here.](https://cheddar.com/videos/gene-munster-tesla-will-fall-short-of-model-3-goals)
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
